Early Skin to Skin in Neonatal Reanimation

Early Skin to Skin in Neonatal reanimation_Risk Assessment in the Newborn With an Umbilical Venous Catheter

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03171844

Acronym

PA2PRéaNice

Enrollment

100

Registered

2017-05-31

Start date

2017-05-31

Completion date

2020-05-06

Last updated

2023-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant, Premature

Brief summary

In the reanimation neonatal department of the Nice's hospital, 34% of newborns admitted have an umbilical vein catheter (KTVO). Their parents are admitted 24h/24h by their side, where everything is done to set up the Attachment (participation in care, skin to skin, support of breastfeeding, ...). The benefits of skin to skin described in developmental care of the newborn in the neonatal health services are well established. Nevertheless, for supposed risks (infectious and displacement of the catheter), registered in the memory of the teams, this care is not currently carried out when the newborns are carrying an umbilical venous catheter. Sometimes, because of the presence of an umbilical venous catheter, parents and their newborns could not enjoy this moment of well-being in the first days of life. We therefore propose a study evaluating the current risks of skin to skin with an umbilical venous catheter by reflecting on a new protocol for laying and fixing this medical device.

Interventions

OTHERSkin to skin

3 sessions of skin to skin will be made on newborn wearing an umbilical venous catheter

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Newborn of gestational age less than 37SA * Admitted in neonatal reanimation department at Nice's hospital * Born in the maternity ward of the Nice's hospital * Carriers of an umbilical venous catheter.

Exclusion criteria

* All newborns with medical contraindications from skin to skin: * Controlled hypothermia protocol * Newborn under HFO (High Frequency Oscillation) * Carrying a diaphragmatic hernia * Thoracic drain holder * With major PAH (hypertensive pulmonary artery) * Symptomatic mother of acute infectious disease * Mother whose physical or psychiatric capacity is not compatible with travel to the neonatal reanimation service within 3 days of delivery. * Minor mother

Design outcomes

Primary

Measure	Time frame	Description
Bacteremia	48h	Occurrence of a bacterial blood infection concomitant with Umbilical venous catheter and up to 48 hours after its withdrawal

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026